VestGen Advisors’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-872
Closed -$472K – 1205
2026
Q2
$472K Buy
872
+292
+50% +$164K 0.01% 688
2026
Q1
$337K Buy
+580
New +$289K 0.01% 801

Other funds holding UTHR

VestGen Advisors's UTHR Position: Q3 2026 in Review

VestGen Advisors sold out of United Therapeutics (UTHR) in Q3 2026, closing a stake of 872 shares — an estimated $472K sold.

VestGen Advisors first reported a position in UTHR in Q1 2026 and held it in 2 quarters. The position peaked at $472K in Q2 2026. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • VestGen Advisors reported no remaining United Therapeutics position as of Q3 2026 after selling out during the quarter.
  • VestGen Advisors sold 872 United Therapeutics shares in Q3 2026, an estimated $472K.
  • VestGen Advisors first reported a position in United Therapeutics in Q1 2026 and held it in 2 quarters.
  • VestGen Advisors's United Therapeutics position peaked at $472K in Q2 2026.
  • 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on VestGen Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.